Company Profile
Terumo provides the manufacture and sale of medical products and equipment globally. Its operations are structured into four segments: Cardiac and Vascular Company, Medical Care Solutions Company, Blood and Cell Technologies Company, and Terumo Organ Technologies.
The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others.
Its portfolio also includes coils, stents, and intrasaccular devices for treating cerebral aneurysm, embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others, oxygenators, cardio-pulmonary bypass systems, and others, and artificial vascular stent grafts, and others.
The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management adhesion barriers, and others.
Its portfolio also includes blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others, and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others.
The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others.
The Terumo Organ Technologies segment provides organ preservation devices. Incorporated in 1921 and headquartered in Shibuya, Japan, Terumo was formerly known as Sekisen Ken-onki Corporation before rebranding in October 1974.